Catalent, Inc. (CTLT) – Will CTLT stock rebound?

in , , on October 31, 2022

This report is useful for M&A and business & investment analysis to all students, researchers, investors, private equity houses, broking firms, hedge funds, advisory firms and corporates to decide upon their investment strategies. Do connect with us, if you are looking for insights on any specific sector/industry and market recommendations.

Catalent, Inc. (CTLT)

CTLT plays a significant role in pharmaceutical industry. The outlook for the Pharmaceuticals sub-industry is positive as the world returns to normalcy. COVID-19 therapies, oncology and immunology are experiencing an increase in demand.

Highlights

Valuation

– Enterprise Value
– CrispIdea Forecast
– CrispIdea Segment Forecast
– Economic Value Added Analysis
– Discounted Cash Flow Analysis
– PE Band Comparison
– Peer Valuation.
– CrispIdea Forecast Relative to Consensus
– Consensus History and Surprise
– Consensus Momentum

Actual & Historical Performance

– Income Statement
– Balance Sheet
– Cash Flow
– 10 Year Historical Performance
– Ratio Analysis
– Du Pont Analysis
– ROIC & ROCE Analysis
– Segment Performance

Peer Performance

– Summary
– Profitability
– Growth
– Price Performance

Ownership

Stock Price Performance

Crispidea Coverage

No of Pages : 33

Release Information

  • Price
    :

    $99.00

  • Released
    :

    October 31, 2022

  • Last Updated
    :

    November 4, 2022